NewslettersHematopoiesis NewsTargeting Pleckstrin-2/Akt Signaling Reduces Proliferation in Myeloproliferative Neoplasm ModelsBy Jamie Kang - March 21, 20230124Researchers revealed a Plek2/Akt complex that drove cell proliferation and could be targeted by a class of antiproliferative compounds for myeloproliferative neoplasm therapy.[Journal Of Clinical Investigation]Full ArticleGraphical Abstract